# Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors

> **NCT01424839** · PHASE4 · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 400 (estimated)

## Conditions studied

- Intracranial Germ Cell Tumors

## Interventions

- **RADIATION:** craniospinal irradiation
- **DRUG:** Carboplatin, Etoposide, Ifosfamide
- **RADIATION:** ventricular irradiation
- **DRUG:** Cisplatin, etoposide, Ifosfamide (standard)
- **DRUG:** Cisplatin, Etoposide, Ifosfamide (high dose)
- **RADIATION:** focal irradiation

## Key facts

- **NCT ID:** NCT01424839
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2015-06-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424839, "Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT01424839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*